Search Within

Dana Elizabeth Rathkopf

  1. "Elsevier Inc."
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (16)
  2. Genitourinary Oncology Service (16)
  3. Solid Tumor Oncology Division (16)
  4. Survivorship Research (5)
  5. GDMT, Radiation Oncology (3)
  6. Gynecology Disease Management Team (3)

More Groups

People
  1. Howard Scher (5)
  2. Michael Morris (5)
  3. Marisa Kollmeier (3)
  4. Daniel Danila (2)
  5. Deaglan McHugh (2)
  6. Richard Bambury (2)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (1)
  6. 2017 (1)

More Years

Publications
  1. European Journal of Cancer (6)
  2. Clinical Genitourinary Cancer (4)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Advances in Radiation Oncology (1)
  5. Journal of Sexual Medicine (1)
  6. Urologic Oncology: Seminars and Original Investigations (1)
Publishers
  1. Elsevier Inc. (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term patient-reported health-related quality of life in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH Agonist with either bicalutamide or abiraterone acetate plus prednisone and apalutamide after radical prostatectomy
    Meeting Abstract

    Hoffman, K. E.; Nguyen, P. L.; Rathkopf, D.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; Bubley, G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Testosterone Recovery and Associated Impact on PatientReported Health -Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial
    Meeting Abstract

    Moningi, S.; Nguyen, P. L.; Rathkopf, D.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; Bubley, G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP)
    Meeting Abstract

    Nguyen, P. L.; Kollmeier, M. A.; Rathkopf, D.; Hoffman, K. E.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
    Journal Article

    Gillessen, S.; Bossi, A.; Davis, I. D.; de Bono, J.; Fizazi, K.; James, N. D.; Mottet, N.; Shore, N.; Small, E.; Smith, M.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
    Journal Article

    Wilson, B. E.; Armstrong, A. J.; de Bono, J.; Sternberg, C. N.; Ryan, C. J.; Scher, H. I.; Smith, M. R.; Rathkopf, D.; Logothetis, C. J.; Chi, K. N.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for oligometastatic prostate cancer
    Journal Article

    Brennan, V.; Spektor, A.; Sweeney, C.; Choudhury, A.; Rathkopf, D.; Pomerantz, M.; Hertan, L.; Nguyen, P.; Martin, N.; Balboni, T.; more...
    Advances in Radiation Oncology (2022)

    Fulltext@MSK | Save
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Genitourinary medical oncology expert opinion survey regarding treatment management in the COVID-19 pandemic
    Journal Article

    Sarfaty, M.; Feldman, D. R.; Morris, M. J.; Motzer, R. J.; Rathkopf, D. E.; Regazzi, A. M.; Iyer, G.; Voss, M. H.; Bajorin, D. F.; Rosenberg, J. E.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • A phase I trial of IGF-1R inhibitor cixutumumab and mTOR inhibitor temsirolimus in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D. J.; Chudow, J.; DeNunzio, M.; Slovin, S. F.; Danila, D. C.; Morris, M. J.; Scher, H. I.; Rathkopf, D. E.
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Does neoadjuvant androgen deprivation therapy impact erectile function recovery post-radical prostatectomy?
    Meeting Abstract

    Jenkins, L.; Touijer, K.; Rathkopf, D.; Nelson, C.; Mulhall, J.
    Journal of Sexual Medicine (2017)

    Fulltext@MSK | Save